<DOC>
	<DOCNO>NCT01442363</DOCNO>
	<brief_summary>This randomize , placebo-controlled , parallel , multi-center , double-blind pilot study design determine effect BLI-1300 ointment perianal pain associate active Perianal Crohn 's Disease ( PCD ) .</brief_summary>
	<brief_title>A Safety Efficacy Study BLI-1300 Ointment Symptomatic Perianal Crohn 's Disease</brief_title>
	<detailed_description />
	<mesh_term>Crohn Disease</mesh_term>
	<criteria>All subject must give write informed consent . Male female subject , 18 year age . Confirmed diagnosis Crohn 's Disease . Subject must 3 month document history perianal Crohn 's Disease ( PCD ) clinical evidence active PCD . Subject must Crohn 's Disease Activity Index ( CDAI ) total score â‰¤ 350 Visit 2 . Subjects must qualify perianal pain score Visits 1 2 . Women childbearing potential use adequate contraception . Women pregnant breastfeeding . Subjects unstable regimen Crohn 's therapy ( e.g . tumor necrosis factor ( TNF ) inhibitor , immunosuppressant , steroid ) . Subjects take strong analgesic could interfere pain measurement . Subjects perianal abscess require incision drainage . Subjects anal stenosis . Subjects fistulae outside immediate perianal area . Subjects abdominal surgery Crohn 's disease within past 12 week . Subjects significant anorectal surgery Crohns disease within past 8 week .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2015</verification_date>
	<keyword>Crohn 's disease</keyword>
	<keyword>perianal</keyword>
	<keyword>inflammatory bowel disease</keyword>
	<keyword>fistula</keyword>
</DOC>